Expression and modulation of the human immunoglobulin A Fc receptor (CD89) and the FcR γ chain on myeloid cells in blood and tissue

Scandinavian Journal of Immunology

Volumn 57, Issue 6, 2003, Pages 506-516

  Hamre, R ^a   Farstad, I N ^a   Brandtzaeg, P ^a   Morton, H C ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CD89 ANTIGEN; FC RECEPTOR; IMMUNOGLOBULIN A; PROTEIN SUBUNIT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN DETECTION; ANTIGEN EXPRESSION; APPENDIX; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA; KIDNEY PARENCHYMA; LIVER; LUNG LAVAGE; LYMPH NODE; MACROPHAGE; MALE; MONOCYTE; NEUTROPHIL; PERITONEAL FLUID; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; TISSUE DISTRIBUTION; TONSIL;

ANTIGENS, CD; CELL DIFFERENTIATION; DENDRITIC CELLS; DOWN-REGULATION; HUMANS; MACROPHAGES; MONOCYTES; MYELOID CELLS; NEUTROPHILS; RECEPTORS, FC; RECEPTORS, IGG; TISSUE DISTRIBUTION;

EID: 0038717098     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.2003.01220.x     Document Type: Article

References (41)

1. Ravetch JV, Kinet JP. Fc receptors. Annu Rev Immunol 1991;9:457-92.
2. Sylvestre DL, Ravetch JV. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 1994;265:1095-8.
3. Clynes R, Ravetch JV. Cytotoxic antibodies trigger inflammation through Fc receptors. Immunity 1995;3:21-6.
4. Hall LR, Diaconu E, Pearlman E. A dominant role for Fcγ receptors in antibody-dependent corneal inflammation. J Immunol 2001;167:919-25.
5. Yuan R, Clynes R, Oh J, Ravetch JV, Scharff MD. Antibody-mediated modulation of Cryptococcus neoformans infection is dependent on distinct Fc receptor functions and IgG subclasses. J Exp Med 1998;187:641-8.
6. + T cell-mediated granulomatous pathology in schistosomiasis is down-regulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med 1998;187:619-29.
7. Clynes R, Takechi Y, Moroi Y, Houghton A, Ravetch JV. Fc receptors are required in passive and active immunity to melanoma. Proc Natl Acad Sci USA 1998;95:652-6.
8. Clynes RA, Towers TL, Presta LG, Ravetch JV. Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets. Nat Med 2000;6:443-6.
9. van Spriel AB, van Ojik HH, van de Winkel JG. Immunotherapeutic perspective for bispecific antibodies. Immunol Today 2000;21:391-7.
10. Valerius T, Stockmeyer B, van Spriel AB et al. FcαRI (CD89) as a novel trigger molecule for bispecific antibody therapy. Blood 1997;90:4485-92.
11. Deo YM, Sundarapandiyan K, Keler T, Wallace PK, Graziano RF. Bispecific molecules directed to the Fc receptor for IgA (FcαRI, CD89) and tumor antigens efficiently promote cell-mediated cytotoxicity of tumor targets in whole blood. J Immunol 1998;160:1677-86.
12. Keler T, Wallace PK, Vitale LA et al. Differential effect of cytokine treatment on Fcα receptor I- and Fcγ receptor I-mediated tumor cytotoxicity by monocyte-derived macrophages. J Immunol 2000;164:5746-52.
13. Stockmeyer B, Dechant M, van Egmond M et al. Triggering Fcα-receptor I (CD89) recruits neutrophils as effector cells for CD20-directed antibody therapy. J Immunol 2000;165:5954-61.
14. Stockmeyer B, Elsasser D, Dechant M et al. Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies. J Immunol Methods 2001;248:103-11.
15. Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L. Expression cloning of a human Fc receptor for IgA. J Exp Med 1990;172:1665-72.
16. Wines BD, Hulett MD, Jamieson GP, Trist HM, Spratt JM, Hogarth PM. Identification of residues in the first domain of human Fcα a receptor essential for interaction with IgA. J Immunol 1999;162:2146-53.
17. Morton HC, van Zandbergen G, van Kooten C, Howard CJ, van de Winkel JG, Brandtzaeg P. Immunoglobulin-binding sites of human FcαRI (CD89) and bovine Fcγ2R are located in their membrane-distal extracellular domains. J Exp Med 1999;189:1715-22.
18. Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM. The interaction of FcαRI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J Immunol 2001;166:1781-9.
19. Keegan AD, Paul WE. Multichain immune recognition receptors: similarities in structure and signaling pathways. Immunol Today 1992;13:63-8.
20. Kinet JP. The γ-ζ dimers of Fc receptors as connectors to signal transduction. Curr Opin Immunol 1992;4:43-8.
21. Cambier JC. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J Immunol 1995;155:3281-5.
22. Morton HC, van den Herik-Oudijk IE, Vossebeld P et al. Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR γ chain. Molecular basis for CD89/FcR γ chain association. J Biol Chem 1995;270:29781-7.
23. Morton HC, Schiel AE, Janssen SW, van de Winkel JG. Alternatively spliced forms of the human myeloid Fcα receptor (CD89) in neutrophils. Immunogenetics 1996;43:246-7.
24. Pleass RJ, Andrews PD, Kerr MA, Woof JM. Alternative splicing of the human IgA Fc receptor CD89 in neutrophils and eosinophils. Biochem J 1996;318:771-7.
25. Patry C, Sibille Y, Lehuen A, Monteiro RC. Identification of Fcα receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J Immunol 1996;156:4442-8.
26. Toyabe S, Kuwano Y, Takeda K, Uchiyama M, Abo T. IgA nephropathy-specific expression of the IgA Fc receptors (CD89) on blood phagocytic cells. Clin Exp Immunol 1997;110:226-32.
27. Glennie MJ, Johnson PW. Clinical trials of antibody therapy. Immunol Today 2000;21:403-10.
28. Cartron G, Dacheux L, Salles G et al. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene. Blood 2002;99:754-8.
29. Morton HC, van Egmond M, van de Winkel JG. Structure and function of human IgA Fc receptors (FcαR). Crit Rev Immunol 1996;16:423-40.
30. van Egmond M, Damen CA, van Spriel AB, Vidarsson G, van Garderen E, van de Winkel JG. IgA and the IgA Fc receptor. Trends Immunol 2001;22:205-11.
31. van Zandbergen G, Westerhuis R, Mohamad NK, van de Winkel JG, Daha MR, van Kooten C. Crosslinking of the human Fc receptor for IgA (FcαRI/CD89) triggers FcR γ-chain-dependent shedding of soluble CD89. J Immunol 1999;163:5806-12.
32. Yamashiro S, Wang JM, Yang D, Gong WH, Kamohara H, Yoshimura T. Expression of CCR6 and CD83 by cytokine-activated human neutrophils. Blood 2000;96:3958-63.
33. Fanger NA, Liu C, Guyre PM et al. Activation of human T cells by major histocompatibility complex class II expressing neutrophils: proliferation in the presence of superantigen, but not tetanus toxoid. Blood 1997;89:4128-35.
34. Smith PD, Smythies LE, Mosteller-Barnum M et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS- and IgA-mediated activities. J Immunol 2001;167:2651-6.
35. Yuan ZN, Gjermo P, Helgeland K, Schenck K. Fcα receptor I (CD89) on neutrophils in periodontal lesions. J Clin Periodontol 2000;27:489-93.
36. Chomarat P, Banchereau J, Davoust J, Palucka AK. IL-6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immun 2000;1:510-4.
37. Geissmann F, Launay P, Pasquier B et al. A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. J Immunol 2000;166:346-52.
38. Heystek HC, Moulon C, Woltman AM, Garonne P, van Kooten C. Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J Immunol 2002;168:102-7.
39. van Egmond M, van Vuuren AJ, Morton HC et al. Human immunoglobulin A receptor (FcaRI, CD89) function in transgenic mice requires both FcR γ chain and CR3 (CD11b/CD18). Blood 1999;93:4387-94.
40. Launay P, Patry C, Lehuen A, Pasquier B, Blank U, Monteiro RC. Alternative endocytic pathway for immunoglobulin A Fc receptors (CD89) depends on the lack of FcRγ association and protects against degradation of bound ligand. J Biol Chem 1999;274:7216-25.
41. Der Boog PJ, van Zandbergen G, de Fijter JW et al. FcαRI/CD89 circulates in human serum covalently linked to IgA in a polymeric state. J Immunol 2002;168:1252-8.